Literature DB >> 7822815

Extension of the four-parameter logistic model for ELISA to multianalyte analysis.

G Jones1, M Wortberg, S B Kreissig, D S Bunch, S J Gee, B D Hammock, D M Rocke.   

Abstract

The standard implementation of enzyme-linked immunosorbent assay (ELISA) for single analytes can lead to false conclusions if cross reacting compounds are present in the sample. This paper discusses the extension of the usual four-parameter logistic model for ELISA to the case of multiple cross-reacting analytes. The use of the extended model in multianalyte analysis (MELISA) is illustrated and compared with a more simplistic approach. Data on the analysis of a binary mixture of s-triazines suggests the superiority of the proposed model. This model is also suitable for other forms of immunoassay that use the four-parameter logistic curve.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822815     DOI: 10.1016/0022-1759(94)90136-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Serum myostatin is reduced in individuals with metabolic syndrome.

Authors:  Der-Sheng Han; Yu Chu-Su; Chih-Kang Chiang; Fen-Yu Tseng; Ping-Huei Tseng; Chi-Ling Chen; Kwan-Dun Wu; Wei-Shiung Yang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

2.  Association of serum myokines and aerobic exercise training in patients with spinal cord injury: an observational study.

Authors:  Der-Sheng Han; Ming-Yen Hsiao; Tyng-Guey Wang; Ssu-Yuan Chen; Wei-Shiung Yang
Journal:  BMC Neurol       Date:  2016-08-17       Impact factor: 2.474

3.  Optimized Lateral Flow Immunoassay Reader for the Detection of Infectious Diseases in Developing Countries.

Authors:  Evdokia Pilavaki; Andreas Demosthenous
Journal:  Sensors (Basel)       Date:  2017-11-20       Impact factor: 3.576

4.  Relation between serum myokines and phase II cardiac rehabilitation.

Authors:  Der-Sheng Han; Ming-Yen Hsiao; Tyng-Guey Wang; Ssu-Yuan Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Myostatin and insulin-like growth factor I: potential therapeutic biomarkers for pompe disease.

Authors:  Yin-Hsiu Chien; Der-Sheng Han; Wuh-Liang Hwu; Beth L Thurberg; Wei-Shiung Yang
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.